Literature DB >> 14702208

Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine.

R W P Rodrigues1, V C Gomide, G Chadi.   

Abstract

Astroglial and microglial activation were analyzed in the ventral tegmental area (VTA) in adult male Wistar rats, after an unilateral striatal 6-hydroxydopamine (6-OHDA) injection. Different doses (8, 4, and 1 microg) of 6-OHDA were injected in the left side of the neostriatum; animals were sacrificed 22 days later. Control animals received an injection of the same volume of the solvent. The tyrosine hydroxylase (TH) positive dopamine cells, the glial fibrillary acidic protein (GFAP) immuno -labeled astrocytes, and the OX42 immunoreactive microglia were visualized by means of immunohistochemistry and quantified by stereologic methods employing the optical dissector and the point intercepts. The number and the density of TH immunoreactive cell bodies were decreased by 45% and 46%, respectively, in the sampled field of the ipsilateral VTA of 8 microg 6-OHDA injected rats. The GFAP immunohistochemistry revealed in the ipsilateral VTA increases the number and density of astroglial cells (154% and 166% of control, respectively) in the rats with a higher dose of the 6-OHDA, and also in the volume fraction of the astroglial processes after 8 microg (41% of control) and 4 microg (24% of control) of 6-OHDA. Increased number (76% of control) and density (77% of control) of OX42 microglial labeled profiles and microglial processes (51% of control) were found in the ipsilateral VTA of the 8 microg 6-OHDA injected animals. These results suggest that the retrograde degeneration of the mesostriatal dopamine pathways, induced by a striatal injection of 6-OHDA, leads to astroglial and microglial reactions in the VTA. The interaction between activated glial cells may be involved in the wounding and repair events in the partial lesioned system, and also in the trophic paracrine responses in the surviving VTA dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14702208     DOI: 10.1080/00207450490249338

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  10 in total

1.  Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

Authors:  A M Fletcher; T H Kowalczyk; L Padegimas; M J Cooper; D M Yurek
Journal:  Neuroscience       Date:  2011-08-04       Impact factor: 3.590

Review 2.  Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage.

Authors:  Jian Wang; Stella E Tsirka
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Differential cellular FGF-2 upregulation in the rat facial nucleus following axotomy, functional electrical stimulation and corticosterone: a possible therapeutic target to Bell's palsy.

Authors:  Karen F Coracini; Caio J Fernandes; Almir F Barbarini; César M Silva; Rodrigo T Scabello; Gabriela P Oliveira; Gerson Chadi
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-11-09

Review 4.  The importance of molecular histology to study glial influence on neurodegenerative disorders. Focus on recent developed single cell laser microdissection.

Authors:  Gerson Chadi; Jessica Ruivo Maximino; Gabriela Pintar de Oliveira
Journal:  J Mol Histol       Date:  2009-11-01       Impact factor: 2.611

5.  Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound.

Authors:  Brian P Mead; Panagiotis Mastorakos; Jung Soo Suk; Alexander L Klibanov; Justin Hanes; Richard J Price
Journal:  J Control Release       Date:  2015-12-28       Impact factor: 9.776

Review 6.  Neural and immune mechanisms in the pathogenesis of Parkinson's disease.

Authors:  Fabio Blandini
Journal:  J Neuroimmune Pharmacol       Date:  2013-02-03       Impact factor: 4.147

7.  Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration.

Authors:  Ilse S Pienaar; Timothy Schallert; Suzél Hattingh; William M U Daniels
Journal:  J Neural Transm (Vienna)       Date:  2009-06-06       Impact factor: 3.575

8.  Organization of GABAergic synaptic circuits in the rat ventral tegmental area.

Authors:  Alessandro Ciccarelli; Arianna Calza; Patrizia Panzanelli; Alessandra Concas; Maurizio Giustetto; Marco Sassoè-Pognetto
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

9.  Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson's Disease Model in Rats.

Authors:  Iana Calou; Mary Anne Bandeira; Wellida Aguiar-Galvão; Gilberto Cerqueira; Rafaelly Siqueira; Kelly Rose Neves; Gerly Anne Brito; Glauce Viana
Journal:  Parkinsons Dis       Date:  2014-06-25

10.  Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine.

Authors:  Daniel Hernandez-Baltazar; Maria E Mendoza-Garrido; Daniel Martinez-Fong
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.